cell surface. These observations establish differences in oligomeric state between PD-1 and other members of the costimulatory receptor family.
Results

PD-1 Is Monomeric in Solution
The extracellular Ig V-type domain of murine PD-1 was expressed in E. coli and refolded in vitro. This purified protein chromatographed as a symmetric monodisperse peak on a calibrated Superdex G-75 (30X1.0) gel filtration column. The elution time of 17.5-18 min corresponds to a molecular weight (MW) of ‫51ف‬ kDa ( Figure  1A ), which is very close to the calculated MW of 13296 Da for the recombinant PD-1 monomer. The similarly refolded, purified human PD-1 protein (calculated MW ϭ 14501 Da) also ran as a ‫51ف‬ kDa monomer on Superdex G-75 gel filtration chromatography (data not shown). The monomeric state of murine PD-1 in solution was confirmed by sedimentation equilibrium analysis ( Figure  1B ). The data are consistent with a single component model with values within error of the monomeric MW of the recombinant murine PD-1. Various self-association models (i.e., monomer ↔ dimer, monomer ↔ trimer, and monomer ↔ tetramer) were examined and are not consistent with the data. Taken together, these results demonstrated that this soluble form of PD-1 is a stable monomer and does not measurably oligomerize in solution.
PD-1 Is Monomeric when Expressed on the Cell Surface
To examine the oligomeric state of PD-1 in a cellular context, the coding regions for the cyan fluorescent protein (CFP) or yellow fluorescent protein (YFP) were fused to the 3Ј end of the full-length murine PD-1 gene. These constructs were cotransfected into CHO cells and the oligomeric state of the full-length protein on the cell valent structure of these molecules (Kenworthy and Edidin, 1998). The distribution of FRET efficiencies for the full-length PD-1 constructs is greatly skewed toward We report here the structural, biophysical, and biochemical features of the Ig V-type domain of murine lower values (relative to the positive controls) with an average value of 6% Ϯ 4%, slightly but significantly PD-1. The crystal structure and structure-based mutagenesis studies of PD-1 identified a ligand binding surhigher than the FRET observed for the negative control ( Figure 2B ). FRET between CPF-PD-1 and YFP-PD-1 face that is significantly different from those of the other members of the CD28/CTLA-4 costimulatory receptor molecules showed a linear dependence on acceptor fluorescence intensity ( Figures 2B and 2C ). This is charfamily. In addition, our data demonstrate that this soluble form of PD-1 is monomeric both in solution and the acteristic of FRET between randomly distributed molecules and is consistent with the presence of unclustered crystalline form. More importantly, fluorescence resonance energy transfer (FRET) studies demonstrate that (i.e., monomeric) PD-1 on the cell surface (Kenworthy and Edidin, 1998). A short form of PD-1 with the cytofull-length PD-1 is monomeric when expressed on the plasmic tail trimmed to 10 residues displayed spectral our recombinant murine PD-1 specifically binds B7-H1-Ig coupled to CM5 sensor chips, suggesting that PD-1 properties similar to the long form ( Figures 2B and 2C) , suggesting that the behavior of the full-length wild-type refolded from inclusion bodies is biologically active. Equilibrium binding assays were performed to determurine PD-1 is not due to the long (94 amino acids), and likely flexible, cytoplasmic tail. Together the data mine the equilibrium dissociation constant (K d ) between murine PD-1 and the B7-H1-Ig fusion protein. Murine strongly support the idea that PD-1 is predominantly present as a monomer on the cell surface. PD-1, over a wide range of concentrations (78.0-0.5 M), was sequentially injected over the sensor chip coupled with murine B7-H1-Ig ( Figure 3A) . At all concentraBinding Affinity of the Murine PD-1/B7-H1 Complex In order to test whether the recombinant PD-1 produced tions examined, binding reached equilibrium within a few seconds, and similarly, complete dissociation was in bacteria retains its biological activity, the interaction between murine PD-1 and the B7-H1-Ig fusion protein achieved within a few seconds after termination of the injections. These observations are consistent with fast was measured by surface plasmon resonance (SPR) using a Biacore X instrument. The results demonstrate that k on and k off rates for the PD-1/B7-H1 interaction. Nonlin-CDR1 loops between PD-1 and CTLA-4 are largely due to their different lengths as shown by the structurebased sequence alignment ( Figure 5C ). Although the difference in the CDR3 loop between PD-1 and CTLA-4 is less obvious based on the superimposition, detailed structural analyses highlight fundamental differences in this region. In the crystal structures of both murine and human CTLA-4, the CDR3 loops are very rigid as indicated by well-defined electron density and relatively low Although there is only about 20% sequence identity I101A, and E103A) were designed for mapping its ligand binding surface. While most of the selected residues between their extracellular Ig V-type domains, a superimposition of the structures of murine PD-1 and CTLA-4 were mutated to Ala, several polar residues were mutated to Ser to minimize adverse effects of the mutation monomers demonstrates that they have very similar overall structures as evidenced by the good overlay on protein refolding and stability. All of the residues selected for mutagenesis have their side chains directed between most of the equivalent ␤ strands (Figures 5A and 5B) (Ostrov et al., 2000) . This structural similarity is toward solvent, and therefore, their mutations are predicted not to significantly affect the hydrophobic core confirmed by the low root mean square (rms) deviation of ‫5.1ف‬ Å between 76 equivalent C ␣ atoms from PD-1 or structural integrity of the PD-1 protein. The majority of these residues are located in or near the hydrophobic and CTLA-4. However, there are significant differences between PD-1 and CTLA-4 involving the C″ strand, CЈC″ patch on the front face ( Figure 1B ). All of the mutants except Q55A and I93A were expressed, refolded, and C″D and CDR1 loops. The most pronounced difference is the placement of the C″ strand that participates in purified at yields comparable to the wild-type. Q55A did not refold under the conditions used to refold the other the back face in CTLA-4 but participates in the front face in PD-1. Structural differences in the CЈC″, C″D and proteins, which may be the consequence of the in- creased hydrophobicity of the protein surface introThe mutants can be divided into several groups based on their abilities to bind the B7-H1 ligand. K45A, I93A, duced by the mutation, since the Q55S mutant refolded just as well as the wild-type. I93A had a significantly L95A, I101A, and E103A have unmeasurable or extremely weak binding activity for the ligand compared lower refolding yield compared to the wild-type and other mutants, but it was reasonably stable after refoldto the wild-type (Figure 6 ; see Supplemental Table S2 at http://www.immunity.com/cgi/content/full/20/3/337/ ing and adequately well behaved for binding assays. The lower refolding efficiency of I93A might be the con-DC1), suggesting side chains of these residues are directly involved in and indispensable for the interaction sequence of a localized structural perturbation caused by the mutation, as I93 is located at the center of the between PD-1 and B7-H1. M31A, N33A, H96A, and K98A display significantly reduced binding compared to the hydrophobic patch. The purified HA-tagged wild-type and all the refolded mutants eluted as monodisperse wild-type (around 42%-67% of wild type) (Figure 6 ; Supplemental Table S2 ), suggesting that they directly particpeaks from the Superdex G-75 column at ‫71ف‬ min, slightly earlier than the elution time of the nontagged ipate in, but are not absolutely required for, ligand binding. Consistent with their important roles in ligand PD-1 (not shown), consistent with the higher MWs of these epitope tagged proteins. Comparable refolding binding, all of the altered residues in these mutants, except M31 and H96, are identical in human and murine efficiency and similar behavior on gel filtration chromatography suggest that these mutants refolded correctly PD-1 ( Figure 5C ). Sequence conservation of residues important for ligand binding between murine and human and have the same overall structure as the wild-type of murine PD-1. Therefore, the measured differences in PD-1 indicates that murine B7-H1 recognizes similar binding surfaces on murine and human PD-1, in agreebinding affinities for the mutants, compared to the wildtype, should directly reflect the contributions of particument with the observed similar binding of B7-H1 by these two receptors. lar residues to the ligand binding activity of murine PD-1.
The binding activities of the HA-tagged and non-Q55S, V57A, and P97A have moderately decreased affinities for the ligand compared to the wild-type tagged wild-type PD-1 were compared by injecting these two proteins at the same concentration over the (around 83%-88% of wild type), whereas N51A and L53A bind the ligand as well as the wild-type of PD-1 same CM5 sensor chip coupled with murine B7-H1-Ig, which resulted in very similar response levels (data not (Figure 6 ; Supplemental Table S2 ). Interestingly, D29A, D29S, and A99L display approximately 10%-20% higher shown). This result indicates that the HA-tag does not significantly affect the binding activity of PD-1 for its binding to the ligand than the wild-type (Figure 6 ; Supplemental Table S2 ). The observation that the A99L muligand. Therefore, all subsequent binding assays utilized the HA-tagged wild-type and mutants of murine PD-1. tation increased rather than abolished ligand binding was surprising, as it was predicted that the substitution The wild-type and mutant proteins, at the same concentration, were sequentially injected over the sensor chips of Ala with a bulky Leu residue would cause steric hindrance in the binding interface, and consequently, precoupled with murine B7-H1-Ig fusion protein, and the response levels of the mutants were compared with that vent PD-1 from interacting with B7-H1. However, considering the high inherent flexibility of the CDR3 loop of the wild-type to obtain the relative ligand binding activities of the mutants.
suggested by the crystal structure, the bulky side chain Figure 5C ). The analo- Table S2 ). Taken together, these results demonstrate gous regions in PD-1 are not highly conserved between that the residues altered in these mutants do not contribhuman and murine sequences ‫%06ف(‬ identity in these ute significant binding energy to the PD-1/B7-H1 interregions versus ‫%56ف‬ identity in the whole extracellular action. H74S and R81S, located on the back sheet and domain) ( Figure 5C ), suggesting that these regions do the interface between the front and back sheets, respecnot play a central role in the structure and function of tively, both exhibit ligand binding activities similar to the PD-1. It should be noted that even in the absence of the wild-type (Figures 6E and 6F ; Supplemental Table S2). interchain disulfide, a significant proportion of CTLA-4 These observations are consistent with the conclusion exists as a noncovalent dimer in solution, demonstrating that the ligand binding surface resides solely on the its inherent tendency to self-associate (Zhang et al., front face of PD-1 ( Figure 7A Table S2 ). Consistent with their modest roles in ligand binding, residues in the CDR3 loop are not strictly conserved between murine and human PD-1 ( Figure 5C ). In contrast, the residues identified to be critical for ligand binding (K45, I93, L95, I101 , and E103) are all contributed from strands in the front face.
Interestingly, a recent mutagenesis study on the ligands of murine PD-1 has also shown that residues from the strands on the front faces, but not those in the CDR3 loops, of both murine B7-H1 and B7-DC are required for binding PD-1 (Wang et al., 2003) . Taken together, these mutagenesis data on both the receptor and ligands suggest that the complexes of PD-1 and its ligands adopt an orthogonal binding mode similar to that of the CD2/CD58 complex (Wang et al., 1999) such that strands from the front faces of the receptor and ligands make the major contribution to the receptor/ ligand interface, whereas the CDR3 loops reside at the periphery of the interface and do not make critical atomic contacts. This interpretation suggests a strandto-strand binding mode for the PD-1/PD-L complexes, which is distinct from the loop-to-strand binding mode observed in the CTLA-4/B7 complexes and also thought to be relevant to the CD28/B7 and ICOS/ B7RP-1 costimulatory complexes ( that encode 3 linker residues and the HA tag) was 5ЈGTAGGATCCT based on the amino acid composition. Buffer density was deter-CAAGCGTAGTCTGGAACATCATACGGGTAGGAGCCACCTGAGGT mined to be 1.0040 cm 3 g -1 using a Mettler De40 density meter CTCCAGGATTCTCTC3Ј. The same mutagenesis strategy was emoperated at the experimental temperature. Absorbance scans were ployed to amplify the HA-tagged mutants of PD-1 (D29A, D29S, taken after 24 and 26 hr and equilibrium was assumed to have been M31A, N33A K45A, N51A, L53A, Q55A, Q55S, V57A, H74S, R81S, reached if the results were unchanged. Data were collected at rotor I93A, L95A, H96A, P97A, K98A, A99L, I101A, and E103A) for ligand speeds of 25,000 rpm and 34,000 rpm after equilibrium was reached binding assays using middle complementary primers containing deand analyzed using Beckman XL-A/XL-I software v4. Analyses consired mutations. A D29A/A99L double mutant was generated using sisted of six scans taken of the three different nominal concentrathe D29A pET3a plasmid as the template. The extracellular Ig V-type tions at each of the two rotor speeds. domain of human PD-1 (129 amino acid residues excluding the initiator Met) was also cloned with the unpaired Cys60 mutated to SPR Binding Assays for PD-1 and B7-H1-Ig Fusion Protein Ser. The flanking 5Ј primer and 3Ј primers were 5ЈGAGGCTCATATG
All binding experiments were carried out using a BIAcore X optical TGGAACCCCCCCACCTTCTCC3Ј and 5ЈGTAGGATCCTCAGGGT biosensor at 25ЊC. Research grade CM5 sensor chips were activated GAGGGGCTGGGGTGGGC3Ј, respectively. The two middle compleby a 7 min injection of a 1:1 mixture of NHS and EDC from the amine mentary primers containing the Cys to Ser mutation were 5ЈCGCAG coupling kit at a flow rate of 5 l/min. 7-15 l of mB7-H1-Ig fusion CCAGCCCGGCCAGGACTCCCGCTTCCGTGTCACACAACTG3Ј and protein (50 g/ml) in 10 mM acetate buffer (pH 5.0) were injected over 5ЈCAGTTGTGTGACACGGAAGCGGGAGTCCTGGCCGGGCTGGCT the experimental flow cell and immobilized to the sensor surface by GCG3Ј. The HA-tagged versions of the wild-type and mutants were free amine coupling chemistry, which typically resulted in immobiliprepared as they represent a highly useful reagent set for future exzation levels of 3500-4000 RUs. 35 l of 1 M ethanolamine (pH 8.5) periments.
was then injected for 7 min to deactivate both the experimental and The proteins were expressed and refolded as described for The HA-tagged mutants of murine PD-1 were injected and the YFP was photobleached using the 514 nm laser line at full power response levels were compared with that of the HA-tagged wildfor 1-2 min. An image of CFP fluorescence and YFP fluorescence type protein injected at the same concentration to obtain the relative after photobleaching was obtained using the respective filter sets.
ligand binding abilities of the mutants. A protein concentration of Data were collected from 10-12 different cells in different fields from 1.7 M (0.025 mg/ml) was used in these assays because this concenthe same coverslip. Two to three regions of interest (located on the tration of wild-type protein yielded high enough, but far from saturatcell membrane) in the photobleached area were selected per cell ing, levels of SPR response shown by the experiments for affinity and the mean CFP fluorescence before and after photobleaching measurement. All of the experiments were repeated at least two was obtained using the Leica Confocal software. FRET efficiency times and the differences between the repeats were negligible was calculated using the following relationship: B7-H1-Ig fusion protein was measured using the same protocol. after photobleaching and D pre is the fluorescence intensity of the CFP before photobleaching. A FRET efficiency of 5% was considered as Crystallization, Data Collection, and Structure Determination the threshold for establishing a significant signal. Students t test Murine PD-1 was crystallized by the hanging drop vapor diffusion (two tailed) was performed to demonstrate the level of significance method by mixing 2 l of protein at 6 mg/ml and 2 l of crystallization between various groups. buffer composed of 20%-30% PEG 8000, 100 mM NaAc, and 100 mM NaCacodylate (pH 6.5). Crystals were flash cooled to 100 K Analytical Ultracentrifugation Analyses for Murine PD-1 under a stream of nitrogen gas in the crystallization buffer supplePurified murine PD-1 was exchanged into a buffer containing 10 mM Tris-HCl and 100 mM NaCl (pH 8.0) using an Amicon concentramented with 15% Glycerol before data collection. Diffraction data
